Our Experience

We understand the processes and the pitfalls of advancing medical device and pharmaceutical technologies from concept to market. We have been Principal Investigators on numerous Phase I and Phase II/IIB NIH and NSF grants, and know the nuances of obtaining non-diultive funding. We have a track record of more than 80 investigational new drug applications (INDs) and investigational device exemptions (IDEs) that have been approved by FDA. We have a trusted network of manufacturing and pre-clinical partners ready to assist in all stages of product development. We have run multi-site clinical trials. We have run meeting with FDA, from pre-IND through End of Phase 2. In short, we are here to assist you in getting your technolgoy to market, no matter what stage of development you are at now.